The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 409.50
Bid: 409.00
Ask: 410.00
Change: 3.50 (0.86%)
Spread: 1.00 (0.244%)
Open: 408.00
High: 409.50
Low: 404.00
Prev. Close: 406.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stress Test Results

28 Jul 2023 17:35

RNS Number : 6282H
Banco Santander S.A.
28 July 2023
 

Banco Santander, S.A. ("Banco Santander"), in compliance with the Securities Market legislation, hereby reports the following:

OTHER RELEVANT INFORMATION

 

Banco Santander reports the results it has obtained in the most recent stress test exercise carried out by the European Banking Authority (EBA) and the European Central Bank (ECB).

The exercise covered a three-year period (end of 2022 - end of 2025) with two scenarios (baseline and adverse) applied to the consolidated perimeter of Santander Group. The CET1 ratio is a financial solvency ratio, the implementation of which is being carried out progressively by financial institutions pursuant to the transitional implementation schedules of the Capital Requirements Directive and Regulation and the International Financial Reporting Standard (IFRS) 9. During the phase-in period of these regulations, in addition to the CET1 Phased-in ratio (a capital ratio calculated pursuant to the transitional regime), which is the legally applicable ratio, the CET1 Fully Loaded ratio (a capital ratio calculated assuming a full implementation of the aforementioned regulations) is also used for information purposes.

The stress test exercise results in the following projected capital ratios for Santander Group for the periods and scenarios considered. A comparison of these projected ratios with the CET1 Fully Loaded ratio (12.04%) and the CET1 Phased-in ratio (12.18%) as of 31 December 2022 is also included in brackets:

 

ADVERSE SCENARIO

BASELINE SCENARIO

 

CET1 Fully Loaded

CET1 Phased- in

CET1 Fully Loaded

CET1 Phased- in

31/12/2023

10.53% (-1.50%)

10.96% (-1.22%)

13.39% (+1.35%)

13.39% (+1.21%)

31/12/2024

10.94% (-1.10%)

11.34% (-0.84%)

14.34% (+2.30%)

14.34% (+2.16%)

31/12/2025

10.33% (-1.70%)

10.33% (-1.84%)

14.44% (+2.40%)

14.44% (+2.26%)

 

Boadilla del Monte (Madrid), 28 July, 2023

 

 

IMPORTANT INFORMATION

Not a securities offer

This document and the information it contains does not constitute an offer to sell nor the solicitation of an offer to buy any securities.

Past performance does not indicate future outcomes

Statements about historical performance or growth rates must not be construed as suggesting that future performance, share price or results (including earnings per share) will necessarily be the same or higher than in a previous period. Nothing in this document should be taken as a profit and loss forecast.

Third Party Information

In this document, Santander relies on and refers to certain information and statistics obtained from publicly-available information and third-party sources, which it believes to be reliable. Neither Santander nor its directors, officers and employees have independently verified the accuracy or completeness of any such publicly-available and third-party information, make any representation or warranty as to the quality, fitness for a particular purpose, non-infringement, accuracy or completeness of such information or undertake any obligation to update such information after the date of this document. In no event shall Santander be liable for any use by any party of, for any decision made or action taken by any party in reliance upon, or for inaccuracies or errors in, or omission from, such publicly-available and third-party information contained herein. Any sources of publicly-available information and third-party information referred or contained herein retain all rights with respect to such information and use of such information herein shall not be deemed to grant a license to any third party.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKXPADFDEFA
Date   Source Headline
3rd Feb 20222:41 pmRNSSREP Capital Requirements 2022
2nd Feb 20228:25 amRNSForm 8.3 - Avast plc
2nd Feb 20227:00 amRNS2021 results report & analyst presentation
2nd Feb 20227:00 amRNS2021 Results - Press release
1st Feb 20223:03 pmRNSNotice of 2021 Results
1st Feb 20229:22 amRNSForm 8.3 - Avast Plc
26th Jan 20221:51 pmRNSForm 8.3 - Avast Plc
25th Jan 20221:40 pmRNSForm 8.3 - Avast plc
14th Jan 20224:16 pmRNSForm 8.3 - Ultra Electronics Holdings plc
11th Jan 202211:19 amRNSForm 8.3 - Meggitt plc
5th Jan 202211:36 amRNSForm 8.3 - Avast Plc
21st Dec 20211:24 pmRNSForm 8.3 - Avast plc
20th Dec 20212:37 pmRNSForm 8.3 - Sanne Group Plc
20th Dec 20212:20 pmRNSForm 8.3 - Meggitt Plc
17th Dec 20219:40 amRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSRating granted by S&P Global Ratings
16th Dec 20212:46 pmRNSForm 8.3 - Meggitt Plc
14th Dec 20215:51 pmRNSBank of Spain formal notification: MREL
10th Dec 202112:02 pmRNSDirector/PDMR Shareholding
8th Dec 20217:00 amRNSFurther re Santander Mexico tender offer: results
7th Dec 20211:03 pmRNSDirector/PDMR Shareholding
30th Nov 202111:01 amRNSForm 8.3 - Meggitt Plc
30th Nov 202110:56 amRNSForm 8.3 - Ultra Electronics Holdings Plc
26th Nov 202112:05 pmRNSEnd of the Programme & 9 - 28 Nov Transactions
24th Nov 20214:41 pmRNSSecond Price Monitoring Extn
24th Nov 20214:35 pmRNSPrice Monitoring Extension
19th Nov 20211:08 pmRNSBuyback programme: transactions 12 Nov - 18 Nov
17th Nov 20211:33 pmRNSForm 8.3 - Ultra Electronics Holdings Plc
17th Nov 20211:30 pmRNSForm 8.3 - Sanne Group Plc
17th Nov 20211:28 pmRNSForm 8.3 - Meggitt Plc
15th Nov 20219:53 amRNSForm 8.3 - Avast Plc
12th Nov 20211:05 pmRNSBuyback programme: transactions 5 Nov - 11 Nov
5th Nov 20211:02 pmRNSBuyback programme: transactions 29 Oct - 4 Nov
29th Oct 20211:04 pmRNSBuyback programme: transactions between 22&28 Oct
29th Oct 20217:00 amRNSSantander Mexico tender offer supplementary info
27th Oct 20217:00 amRNS3Q2021 results report & analyst presentation
27th Oct 20217:00 amRNS3rd Quarter 2021 Results - Press release
26th Oct 20213:14 pmRNS3rd Quarter Results announcement
22nd Oct 20211:06 pmRNSBuyback programme: transactions between 15&21 Oct
19th Oct 202110:55 amRNSForm 8.3 - Meggitt plc
15th Oct 20211:09 pmRNSBuyback programme: transactions between 6&14 Oct
6th Oct 20217:12 amRNSCommencement of a program to repurchase own shares
5th Oct 20219:39 amRNSForm 8.3 - Avast Plc
30th Sep 20213:22 pmRNSForm 8.3 - Avast Plc
30th Sep 20213:17 pmRNSForm 8.3 - Meggitt Plc
30th Sep 20213:16 pmRNSForm 8.3 - Meggitt Plc
30th Sep 20211:25 pmRNSHalf-yearly Financial Report
28th Sep 20215:55 pmRNSDividend Declaration
15th Sep 20215:50 pmRNSIssue of Debt
15th Sep 20211:16 pmRNSForm 8.3 - Sanne Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.